tiprankstipranks
Trending News
More News >
Kiora Pharmaceuticals (KPRX)
NASDAQ:KPRX
US Market

Kiora Pharmaceuticals (KPRX) Ratios

Compare
468 Followers

Kiora Pharmaceuticals Ratios

KPRX's free cash flow for Q4 2024 was $0.00. For the 2024 fiscal year, KPRX's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
4.94 2.90 2.35 5.59 1.02
Quick Ratio
4.94 2.90 2.35 5.59 1.02
Cash Ratio
0.63 1.50 1.82 4.88 0.67
Solvency Ratio
0.34 -1.64 -1.85 -1.83 -0.97
Operating Cash Flow Ratio
1.42 -5.85 -3.19 -6.76 -4.13
Short-Term Operating Cash Flow Coverage
366.48 0.00 -98.58 -91.61 -34.47
Net Current Asset Value
$ 18.98M$ -2.86M$ 410.01K$ 157.39K$ -6.35M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 0.01 0.02
Debt-to-Equity Ratio
<0.01 0.02 <0.01 0.02 0.05
Debt-to-Capital Ratio
<0.01 0.02 <0.01 0.02 0.05
Long-Term Debt-to-Capital Ratio
<0.01 0.00 0.00 0.00 0.04
Financial Leverage Ratio
1.42 2.24 1.64 1.96 2.17
Debt Service Coverage Ratio
81.15 -1.12K -117.51 -106.80 -30.75
Interest Coverage Ratio
210.31 -1.13K -1.43K -2.47K -1.96K
Debt to Market Cap
<0.01 0.00 <0.01 <0.01 <0.01
Interest Debt Per Share
0.02 0.22 0.16 0.90 3.19
Net Debt to EBITDA
-0.66 0.19 0.43 0.56 0.12
Profitability Margins
Gross Profit Margin
100.00%0.00%0.00%0.00%-1560.34%
EBIT Margin
35.46%0.00%0.00%0.00%-56766.97%
EBITDA Margin
35.58%0.00%0.00%0.00%-55106.60%
Operating Profit Margin
28.15%0.00%0.00%0.00%-67911.24%
Pretax Profit Margin
35.33%0.00%0.00%0.00%-67002.94%
Net Profit Margin
22.44%0.00%0.00%0.00%-67102.91%
Continuous Operations Profit Margin
22.44%0.00%0.00%0.00%-56901.65%
Net Income Per EBT
63.51%100.73%99.17%98.17%100.15%
EBT Per EBIT
125.49%98.70%111.27%98.57%98.66%
Return on Assets (ROA)
9.85%-91.26%-72.72%-90.79%-53.39%
Return on Equity (ROE)
13.95%-204.82%-119.08%-177.73%-115.61%
Return on Capital Employed (ROCE)
14.80%-104.21%-79.90%-103.00%-61.18%
Return on Invested Capital (ROIC)
9.39%-104.56%-78.17%-99.68%-60.10%
Return on Tangible Assets
12.06%-255.49%-171.18%-175.12%-416.51%
Earnings Yield
28.13%-494.89%-60.09%-12.51%-3.97%
Efficiency Ratios
Receivables Turnover
18.38 0.00 0.00 0.00 0.13
Payables Turnover
0.00 19.52 0.13 1.41 0.46
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
256.72 0.00 0.00 0.00 0.39
Asset Turnover
0.44 0.00 0.00 0.00 <0.01
Working Capital Turnover Ratio
1.20 0.00 0.00 0.00 <0.01
Cash Conversion Cycle
19.85 -18.69 -2.75K -257.96 1.96K
Days of Sales Outstanding
19.85 0.00 0.00 0.00 2.75K
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
0.00 18.69 2.75K 257.96 792.57
Operating Cycle
19.85 0.00 0.00 0.00 2.75K
Cash Flow Ratios
Operating Cash Flow Per Share
2.21 -17.76 -14.24 -45.16 -63.75
Free Cash Flow Per Share
2.21 -17.76 -14.24 -45.42 -64.91
CapEx Per Share
<0.01 <0.01 0.00 0.26 1.17
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.01 1.02
Dividend Paid and CapEx Coverage Ratio
1.37K -9.56M 0.00 -170.48 -54.69
Capital Expenditure Coverage Ratio
1.37K -9.56M 0.00 -170.48 -54.69
Operating Cash Flow Coverage Ratio
149.71 -89.41 -98.58 -51.99 -20.21
Operating Cash Flow to Sales Ratio
0.53 0.00 0.00 0.00 -606.78
Free Cash Flow Yield
66.93%-377.95%-46.13%-8.36%-3.66%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
3.56 -0.20 -1.66 -7.99 -25.18
Price-to-Sales (P/S) Ratio
0.80 0.00 0.00 0.00 16.89K
Price-to-Book (P/B) Ratio
0.50 0.41 1.98 14.21 29.11
Price-to-Free Cash Flow (P/FCF) Ratio
1.49 -0.26 -2.17 -11.97 -27.34
Price-to-Operating Cash Flow Ratio
1.49 -0.26 -2.17 -12.04 -27.84
Price-to-Earnings Growth (PEG) Ratio
-0.03 >-0.01 0.02 2.25 1.20
Price-to-Fair Value
0.50 0.41 1.98 14.21 29.11
Enterprise Value Multiple
1.59 -0.01 -1.24 -8.99 -30.53
Enterprise Value
EV to EBITDA
1.59 -0.01 -1.24 -8.99 -30.53
EV to Sales
0.56 0.00 0.00 0.00 16.83K
EV to Free Cash Flow
1.06 -0.02 -1.61 -11.27 -27.23
EV to Operating Cash Flow
1.06 -0.02 -1.61 -11.34 -27.73
Tangible Book Value Per Share
4.92 -5.03 0.91 2.19 -54.15
Shareholders’ Equity Per Share
6.65 11.36 15.58 38.26 60.98
Tax and Other Ratios
Effective Tax Rate
0.36 >-0.01 <0.01 0.02 >-0.01
Revenue Per Share
4.14 0.00 0.00 0.00 0.11
Net Income Per Share
0.93 -23.26 -18.55 -68.00 -70.50
Tax Burden
0.64 1.01 0.99 0.98 1.00
Interest Burden
1.00 1.00 1.28 1.20 1.18
Research & Development to Revenue
0.49 0.00 0.00 0.00 295.72
SG&A to Revenue
0.35 0.00 0.00 0.00 386.33
Stock-Based Compensation to Revenue
0.04 0.00 0.00 0.00 60.03
Income Quality
2.38 0.76 0.77 0.66 0.90
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis